Cross-site scripting in Oracle Healthcare Translational Research



Published: 2020-07-16
Risk Low
Patch available YES
Number of vulnerabilities 1
CVE-ID CVE-2020-11022
CWE-ID CWE-79
Exploitation vector Network
Public exploit Public exploit code for vulnerability #1 is available.
Vulnerable software
Subscribe
Oracle Healthcare Translational Research
Web applications / CRM systems

Vendor Oracle

Security Bulletin

This security bulletin contains one low risk vulnerability.

1) Cross-site scripting

EUVDB-ID: #VU27052

Risk: Low

CVSSv3.1: 5.5 [CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N/E:P/RL:O/RC:C]

CVE-ID: CVE-2020-11022

CWE-ID: CWE-79 - Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

Exploit availability: Yes

Description

The disclosed vulnerability allows a remote attacker to perform cross-site scripting (XSS) attacks.

The vulnerability exists due to insufficient sanitization of user-supplied data in the regex operation in "jQuery.htmlPrefilter". A remote attacker can pass specially crafted data to the application that uses .html(), .append() or similar methods for it and execute arbitrary JavaScript code in user's browser in context of vulnerable website.

Successful exploitation of this vulnerability may allow a remote attacker to steal potentially sensitive information, change appearance of the web page, perform phishing and drive-by-download attacks.

Mitigation

Install update from vendor's website.

Vulnerable software versions

Oracle Healthcare Translational Research: 3.2.1 - 3.4.0


CPE2.3 External links

http://www.oracle.com/security-alerts/cpujul2020.html?837375

Q & A

Can this vulnerability be exploited remotely?

Yes. This vulnerability can be exploited by a remote non-authenticated attacker via the Internet.

Is there known malware, which exploits this vulnerability?

No. We are not aware of malware exploiting this vulnerability. However, proof of concept for this vulnerability is available.



###SIDEBAR###